28th Dec 2006 16:36
Synexus Clinical Research PLC28 December 2006 SYNEXUS CLINICAL RESEARCH PLC (the "Company") GRANT OF OPTIONS On 22 December 2006, options over 116,290 ordinary shares of 10p each in SynexusClinical Research PLC were granted to Paul McCluskey, a director of the Company,in accordance with the Rules of the EMI Scheme and Unapproved Share OptionScheme. The options are exercisable in the period 21 December 2006 to 21December 2016 at a price of 99.5p per share and represent Paul McCluskey's onlyinterest in the issued share capital of the Company. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Synectics